Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing
Background: Glioblastomas are malignant, often incurable brain tumors. Reliable discrimination between recurrent disease and treatment changes is a significant challenge. Prior work has suggested glioblastoma FDG PET conspicuity is improved at delayed time points vs. conventional imaging times. This...
Guardado en:
Autores principales: | Jason Michael Johnson, Melissa M. Chen, Eric M. Rohren, Sujit Prabhu, Beth Chasen, Osama Mawlawi, Ho-Ling Liu, Maria Kristine Gule-Monroe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ff55c1dc5b34c658800dd316d1fe54e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [<sup>18</sup>F]FDG PET/CT in Metastatic Melanomas and Lung Cancer
por: Egesta Lopci
Publicado: (2021) -
Proliferation PET/CT Imaging of Salivary Gland Tumor
por: Ryogo Minamimoto
Publicado: (2021) -
Extrahepatic metastases of hepatocellular carcinoma on 18F FDG PET CT
por: Manjit Sarma, et al.
Publicado: (2021) -
FDG PET/CT in follow UP patients with colorectal carcinoma after adjuvant chemotherapy
por: Remon Zaher Elia, et al.
Publicado: (2021) -
Evaluation of Age and Sex-Related Metabolic Changes in Healthy Subjects: An Italian Brain 18F-FDG PET Study
por: Michela Allocca, et al.
Publicado: (2021)